NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-026-2016-0-HU-01 Compounds for Improving MRNA Splicing HU EP 16737944.5 Issued
NCATS E-026-2016-0-IE-01 Compounds for Improving MRNA Splicing IE EP 16737944.5 Issued
NCATS E-026-2016-0-IT-01 Compounds for Improving MRNA Splicing IT EP 16737944.5 Issued
NCATS E-026-2016-0-NL-01 Compounds for Improving MRNA Splicing NL EP 16737944.5 Issued
NCATS E-026-2016-0-GB-01 Compounds for Improving MRNA Splicing GB EP 16737944.5 Issued
NCATS E-026-2016-0-TR-01 Compounds for Improving MRNA Splicing TR EP 16737944.5 Issued
NCATS E-026-2016-0-CH-01 Compounds for Improving MRNA Splicing CH EP 16737944.5 Issued
NCATS E-026-2016-0-FI-01 Compounds for Improving MRNA Splicing FI EP 16737944.5 Issued
NCATS E-026-2016-0-FR-01 Compounds for Improving MRNA Splicing FR EP 16737944.5 Issued
NCATS E-026-2016-0-DE-01 Compounds for Improving MRNA Splicing DE EP 16737944.5 Issued
NCATS E-026-2016-0-SK-01 Compounds for Improving MRNA Splicing SK EP 16737944.5 Issued
NCATS E-026-2016-0-RO-01 Compounds for Improving MRNA Splicing RO EP 16737944.5 Issued
NCATS E-026-2016-0-PT-01 Compounds for Improving MRNA Splicing PT EP 16737944.5 Issued
NCATS E-026-2016-0-SE-01 Compounds for Improving MRNA Splicing SE EP 16737944.5 Issued
NCATS E-026-2016-0-SI-01 Compounds for Improving MRNA Splicing SI EP 16737944.5 Issued
NCATS E-026-2016-0-ES-01 Compounds for Improving MRNA Splicing ES EP 16737944.5 Issued
NCATS E-026-2016-0-PL-01 Compounds for Improving MRNA Splicing PL EP 16737944.5 Issued
NCATS E-026-2016-0-NO-01 Compounds for Improving MRNA Splicing NO EP 16737944.5 Issued
NCATS E-026-2016-0-BE-01 Compounds for Improving MRNA Splicing BE EP 16737944.5 Issued
NCATS E-026-2016-0-AT-01 Compounds for Improving MRNA Splicing AT EP 16737944.5 Issued
NCATS E-026-2016-0-IL-07 Compounds for Improving MRNA Splicing IL National Stage 253291 Issued
NCATS E-026-2016-0-TW-04 Compounds for Improving mRNA Splicing TW ORD 105101315 Issued
NCATS E-026-2016-0-EA-13 Compounds for Improving MRNA Splicing EA National Stage 201791624 Issued
NCATS E-026-2016-0-AU-14 Compounds for Improving MRNA Splicing AU National Stage 2016206589 Issued
NCI E-495-2013-0-JP-07 Anti-Human Papillomavirus 16 E6 T Cell Receptors JP National Stage 2016-527006 Issued
NCI E-494-2013-0-JP-07 Methods of Preparing Anti-human Papillomavirus Antigen T Cells JP National Stage 2016-527005 Issued
NCATS E-026-2016-0-PCT-03 Compounds for Improving MRNA Splicing PCT PCT PCT/US2016/013553 Expired
NCI E-122-2015-1-PCT-02 Virus-like Particles With Efficient Epitope Display PCT PCT PCT/DK2016/050011 Expired
NCATS E-026-2016-0-EP-01 Compounds for Improving MRNA Splicing EP DIV 22178466.3 Abandoned
NCATS E-282-2014-0-PCT-02 Inhibitors Of 3-phosphoglycerate Dehydrogenase and Uses Thereof PCT PCT PCT/US16/013602 Expired
NCATS E-026-2016-0-BR-18 Compounds for Improving MRNA Splicing BR National Stage BR112017015019-0 Pending
NCATS E-026-2016-0-MX-01 Compounds for Improving MRNA Splicing MX DIV MX/a/2022/015737 Pending
NCATS E-026-2016-0-MX-08 Compounds for Improving MRNA Splicing MX National Stage MX/a/2017/009295 Pending
NCATS E-026-2016-0-ZA-11 Compounds for Improving MRNA Splicing ZA National Stage 2017/04699 Pending
NCATS E-026-2016-0-IL-16 Compounds for Improving MRNA Splicing IL DIV 2045-09-27 Pending
NCI E-495-2013-0-US-08 Anti-Human Papillomavirus 16 E6 T Cell Receptors US National Stage 14/905,108 9822162 Issued PDF
NCI E-494-2013-0-US-09 Methods Of Preparing Anti-Human Papillomavirus Antigen T Cells US National Stage 14/905,138 Abandoned
NCI E-148-2011-0-US-10 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use of Same For The Treatment Of Cancer US DIV 14/994,403 9624306 Issued PDF
NIAAA E-316-2013-0-CN-07 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate CN National Stage 105246870 Pending
NCI E-482-2013-0-US-05 Photoactivable Lipid-based Nanoparticles As Vehicles For Dual Agent Delivery US National Stage 14/904,385 10117942 Issued PDF
NCI E-275-2014-0-CN-07 Furoquinolinedione As Inhibitors Of TDP2 CN National Stage 201680014742.7 Issued
NCI E-275-2014-0-AU-03 Furoquinolinedione As Inhibitors Of TDP2 AU National Stage 2016205137 Issued
NCI E-275-2014-0-EP-05 Furoquinolinedione As Inhibitors Of TDP2 EP National Stage 16703001.4 Issued
NCI E-275-2014-0-GB-10 Furoquinolinedione As Inhibitors Of TDP2 GB EP 16703001.4 Issued
NCI E-275-2014-0-DE-08 Furoquinolinedione As Inhibitors Of TDP2 DE EP 16703001.4 Issued
NCI E-275-2014-0-FR-09 Furoquinolinedione As Inhibitors Of TDP2 FR EP 16703001.4 Issued
NCI E-121-2013-0-US-04 Method for the Diagnosis and Prognosis of Cancer US National Stage 14/903,706 10393745 Issued PDF
NCI E-119-2013-0-US-03 Method for Synthesizing Selectively Labeled RNA US National Stage 14/903,738 10190143 Issued PDF
NCI E-767-2013-0-US-07 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules US National Stage 14/903,659 10053514 Issued PDF
NCI E-275-2014-0-PCT-02 Furoquinolinedione As Inhibitors Of TDP2 PCT PCT PCT/US2016/012672 Expired